Aliskiren Hemifumarate/Amlodipine Besylate
半延胡索酸阿利吉仑/苯磺酸氨氯地平
Report date: 2026/01/21 14:10:58
Base Information
Drug NameAliskiren Hemifumarate/Amlodipine Besylate
Drug Alias Name +[7]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date2010/08/26
Country/Territory +[22]
CombinationsYes Aliskiren HemifumarateAmlodipine Besylate
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A
Develop Information
Active CompaniesBeijing Novartis Pharma Co Ltd
Inactive CompaniesNovartis Pharma AgNovartis Europharm Ltd
Active Indications
Inactive Indications
Other Information
ATC Code
Related LinksKEGG